Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-06-22

Clinical Trial Update: Prevention of Asthma and Allergy by Probiotic Lactobacillus GG [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether the probiotic Lactobacillus GG can prevent allergic asthma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus GG (Lactobacillus rhamnosus GG)

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Allergic Asthma | Phase 4 | Status: COMPLETED